Search clinical trials for: AZD2115
Total 145 results
-
AstraZenecaCompleted
-
AstraZenecaTerminatedAcute Myeloid LeukaemiaUnited States, Australia
-
Samsung Medical CenterWithdrawn
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung Disease Causing Persistent Narrowing of the AirwaysUnited Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompleted
-
AstraZenecaTerminated
-
AstraZenecaTerminated
-
AstraZenecaCompletedStudy to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male SubjectsRefluxNetherlands, Belgium
-
AstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid TumoursUnited States
-
AstraZenecaCompletedAcute Myeloid LeukaemiaUnited Kingdom
-
Samsung Medical CenterWithdrawnSolid TumorKorea, Republic of
-
Massachusetts General HospitalUnited States Department of Defense; AstraZenecaCompletedMeningioma | Neurofibromatosis 2United States
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
Oxford University Hospitals NHS TrustUniversity of Manchester; The Christie NHS Foundation Trust; Early Phase Cancer...Completed
-
AstraZenecaCompletedMyeloid LeukemiaUnited States, Italy, Netherlands, France
-
AstraZenecaCompletedAcute Myeloid LeukaemiaJapan
-
Angitia Incorporated LimitedRecruitingOsteogenesis ImperfectaUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); AstraZenecaActive, not recruiting
-
Samsung Medical CenterAstraZenecaTerminatedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years. | Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80United Kingdom
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompletedAdvanced CancerUnited Kingdom
-
AstraZenecaTerminatedThrombin InhibitionUnited States
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
AstraZenecaActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaCompletedGlioblastoma MultiformeCanada
-
AstraZenecaParexelTerminated
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Samsung Medical CenterTerminatedCancer of StomachKorea, Republic of
-
Samsung Medical CenterTerminatedStomach NeoplasmsKorea, Republic of
-
AstraZenecaTerminatedHealthyUnited Kingdom
-
The Christie NHS Foundation TrustAstraZeneca; Cancer Research UKTerminatedRectal CancerUnited Kingdom
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownSquamous Cell Lung Cancer | Triple-Negative Breast Cancer | Non-squamous Cell Lung Cancer With KRAS Mutations | Non-squamous Cell Lung Cancer With Wild-type KRASUnited Kingdom
-
National Cancer Institute (NCI)TerminatedNeurofibromatosis Type 1 | Plexiform Neurofibroma | Spinal Cord NeurofibromaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood... and other conditionsUnited States
-
AstraZenecaCompletedAcute Myeloid LeukemiaUnited States, Italy, United Kingdom, Romania, Japan, Australia, Germany, Spain, France
-
Cambridge University Hospitals NHS Foundation TrustAstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditionsUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
AstraZenecaCompletedCOVID-19 | SARS-CoV-2United Kingdom, Brazil, South Africa, Poland
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerCanada
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of
-
AstraZenecaCompletedHepatic Impairment | Advanced CancerNetherlands, Denmark